Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$705.89 - $766.39 $2,823 - $3,065
4 New
4 $2,000
Q3 2020

Nov 09, 2020

SELL
$544.75 - $658.21 $33,229 - $40,150
-61 Reduced 93.85%
4 $2,000
Q4 2018

Feb 12, 2019

BUY
$335.82 - $403.04 $20,485 - $24,585
61 Added 1525.0%
65 $24,000
Q2 2018

Aug 10, 2018

SELL
$284.6 - $344.99 $5.08 Million - $6.16 Million
-17,855 Reduced 99.98%
4 $1,000
Q1 2018

May 11, 2018

BUY
$315.82 - $393.78 $2.73 Million - $3.4 Million
8,635 Added 93.61%
17,859 $6.15 Million
Q4 2017

Feb 12, 2018

BUY
$358.63 - $469.95 $3.31 Million - $4.33 Million
9,224
9,224 $3.47 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.5B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track May Tech Global Investments, LLC Portfolio

Follow May Tech Global Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of May Tech Global Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on May Tech Global Investments, LLC with notifications on news.